EHS
EHS

Women more likely to experience key side effects from chemotherapy for esophagogastric cancer

MUNICH — Women appeared more likely than men to experience certain side effects from first-line chemotherapy for esophagogastric cancer, according to study results presented at European Society for Medical Oncology Congress.
Sex contributes to variations in dose-response relationships and chemotherapy metabolism between men and women, potentially affecting toxicity and efficacy. However, comparative data on the effect sex has on chemotherapy-related toxicity for first-line treatment of esophagogastric cancer are lacking, according to study background.
“We have known for a long time

Source link

EHS
Back to top button